{
 "drug": "Tiagabine Hydrochloride Tablet",
 "asOf": "2026-08-25",
 "status": "discontinuing",
 "since": "04/15/2026",
 "dayN": 132,
 "cat": "Neurology",
 "companies": [
  "Teva Pharmaceuticals USA, Inc."
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "04/15/2026",
   "update_type": "New",
   "initial_posting_date": "04/15/2026",
   "package_ndc": "0093-5031-56",
   "generic_name": "Tiagabine Hydrochloride Tablet",
   "contact_info": "888-838-2872",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "NDA020646"
    ],
    "brand_name": [
     "TIAGABINE HYDROCHLORIDE"
    ],
    "generic_name": [
     "TIAGABINE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Teva Pharmaceuticals USA, Inc."
    ],
    "product_ndc": [
     "0093-5031",
     "0093-5030",
     "0093-8072",
     "0093-8076"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "TIAGABINE HYDROCHLORIDE"
    ],
    "rxcui": [
     "1299903",
     "1299909",
     "1299911",
     "1299917"
    ],
    "spl_id": [
     "2a8d7987-54ae-45d7-8224-361dac37e0a4"
    ],
    "spl_set_id": [
     "953ef3cc-e3cb-480f-b9ea-256520fd62b8"
    ],
    "package_ndc": [
     "0093-5030-56",
     "0093-5031-56",
     "0093-8072-56",
     "0093-8076-56"
    ],
    "unii": [
     "DQH6T6D8OY"
    ]
   },
   "update_date": "04/15/2026",
   "therapeutic_category": [
    "Neurology"
   ],
   "dosage_form": "Tablet",
   "presentation": "Tiagabine Hydrochloride, Tablet, 4mg 30 count (NDC 0093-5031-56)",
   "company_name": "Teva Pharmaceuticals USA, Inc.",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "04/15/2026",
   "update_type": "New",
   "initial_posting_date": "04/15/2026",
   "package_ndc": "0093-5030-56",
   "generic_name": "Tiagabine Hydrochloride Tablet",
   "contact_info": "888-838-2872",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "NDA020646"
    ],
    "brand_name": [
     "TIAGABINE HYDROCHLORIDE"
    ],
    "generic_name": [
     "TIAGABINE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Teva Pharmaceuticals USA, Inc."
    ],
    "product_ndc": [
     "0093-5030",
     "0093-5031",
     "0093-8072",
     "0093-8076"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "TIAGABINE HYDROCHLORIDE"
    ],
    "rxcui": [
     "1299903",
     "1299909",
     "1299911",
     "1299917"
    ],
    "spl_id": [
     "2a8d7987-54ae-45d7-8224-361dac37e0a4"
    ],
    "spl_set_id": [
     "953ef3cc-e3cb-480f-b9ea-256520fd62b8"
    ],
    "package_ndc": [
     "0093-5030-56",
     "0093-5031-56",
     "0093-8072-56",
     "0093-8076-56"
    ],
    "unii": [
     "DQH6T6D8OY"
    ]
   },
   "update_date": "04/15/2026",
   "therapeutic_category": [
    "Neurology"
   ],
   "dosage_form": "Tablet",
   "presentation": "Tiagabine Hydrochloride, Tablet, 2mg 30 count (NDC 0093-5030-56)",
   "company_name": "Teva Pharmaceuticals USA, Inc.",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "04/15/2026",
   "update_type": "New",
   "initial_posting_date": "04/15/2026",
   "package_ndc": "0093-8076-56",
   "generic_name": "Tiagabine Hydrochloride Tablet",
   "contact_info": "888-838-2872",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "NDA020646"
    ],
    "brand_name": [
     "TIAGABINE HYDROCHLORIDE"
    ],
    "generic_name": [
     "TIAGABINE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Teva Pharmaceuticals USA, Inc."
    ],
    "product_ndc": [
     "0093-8076",
     "0093-5030",
     "0093-5031",
     "0093-8072"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "TIAGABINE HYDROCHLORIDE"
    ],
    "rxcui": [
     "1299903",
     "1299909",
     "1299911",
     "1299917"
    ],
    "spl_id": [
     "2a8d7987-54ae-45d7-8224-361dac37e0a4"
    ],
    "spl_set_id": [
     "953ef3cc-e3cb-480f-b9ea-256520fd62b8"
    ],
    "package_ndc": [
     "0093-5030-56",
     "0093-5031-56",
     "0093-8072-56",
     "0093-8076-56"
    ],
    "unii": [
     "DQH6T6D8OY"
    ]
   },
   "update_date": "04/15/2026",
   "therapeutic_category": [
    "Neurology"
   ],
   "dosage_form": "Tablet",
   "presentation": "Tiagabine Hydrochloride, Tablet, 16mg 30 count (NDC 0093-8076-56)",
   "company_name": "Teva Pharmaceuticals USA, Inc.",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "04/15/2026",
   "update_type": "New",
   "initial_posting_date": "04/15/2026",
   "package_ndc": "0093-8072-56",
   "generic_name": "Tiagabine Hydrochloride Tablet",
   "contact_info": "888-838-2872",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "NDA020646"
    ],
    "brand_name": [
     "TIAGABINE HYDROCHLORIDE"
    ],
    "generic_name": [
     "TIAGABINE HYDROCHLORIDE"
    ],
    "manufacturer_name": [
     "Teva Pharmaceuticals USA, Inc."
    ],
    "product_ndc": [
     "0093-8072",
     "0093-5030",
     "0093-5031",
     "0093-8076"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "TIAGABINE HYDROCHLORIDE"
    ],
    "rxcui": [
     "1299903",
     "1299909",
     "1299911",
     "1299917"
    ],
    "spl_id": [
     "2a8d7987-54ae-45d7-8224-361dac37e0a4"
    ],
    "spl_set_id": [
     "953ef3cc-e3cb-480f-b9ea-256520fd62b8"
    ],
    "package_ndc": [
     "0093-5030-56",
     "0093-5031-56",
     "0093-8072-56",
     "0093-8076-56"
    ],
    "unii": [
     "DQH6T6D8OY"
    ]
   },
   "update_date": "04/15/2026",
   "therapeutic_category": [
    "Neurology"
   ],
   "dosage_form": "Tablet",
   "presentation": "Tiagabine Hydrochloride, Tablet, 12mg 30 count (NDC 0093-8072-56)",
   "company_name": "Teva Pharmaceuticals USA, Inc.",
   "status": "To Be Discontinued"
  }
 ]
}